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PKCd Clustering at the Leading Edge and Mediating
Growth Factor-Enhanced, but not ECM-Initiated,
Dermal Fibroblast Migration
Jianhua Fan1,2,4, Shengxi Guan1,4, Chieh-Fang Cheng1, Michele Cho1, Joshua W. Fields1, Mei Chen1,
Mitchell F. Denning3, David T. Woodley1,2 and Wei Li1,2
We have previously shown that the immobilized extracellular matrices (ECMs) initiate cell migration and soluble
growth factors (GFs) further enhance ECM-initiated cell migration. GFs alone cannot initiate cell migration. To
further investigate the specificity of the two signaling mechanisms, we focused on the protein kinase C (PKC)
family genes in primary human dermal fibroblasts (DFs). We here show that platelet-derived growth factor-BB
(PDGF-BB) strongly stimulates membrane translocation and leading edge clustering of protein kinase Cd (PKCd).
In contrast, attachment to collagen matrix alone does not cause the translocation. Although the kinase function
of PKCd is dispensable for initial membrane translocation, it is critical for its sustained presence at the cells’s
leading edge. Blockade of endogenous PKCd signaling with dominant-negative kinase-defective PKC (PKCd-KD)
or PKCd-small interfering RNA (siRNA) completely inhibited PDGF-BB-stimulated DF migration. In contrast,
neither PKCd-KD nor PKCd-siRNA affected collagen-induced initiation of DF migration. Overexpression of a
constitutively activated PKCd (PKCd-R144/145A) partially mimics the effect of PDGF-BB. However, PKCd-KD,
PKCd-siRNA, or PKCd-R144/145A does not affect PDGF-BB-stimulated activation of p38 mitogen-activated protein
kinase, extracellular signal-regulated kinase1/2, or c-Jun N-terminal kinase. Instead, inhibition of PKCd blocks
PDGF-BB-stimulated activation of signal transducer and activator of transcription 3 (Stat3). This study unveiled
the specificity of PKCd in the control of DF migration.
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INTRODUCTION
Cell migration is the result of repeated cycles of cytoskelaton-
mediated cell polarization, adhesion, contraction, and
retraction at the trailing edge (Lauffenburger and Horwitz,
1996). These sequential events are initiated and further
driven by two extracellular environmental cues, the extra-
cellular matrices (ECMs) and soluble growth factors (GFs)
(Eliceiri, 2000; Schwartz and Ginsberg, 2002). The detailed
mechanisms, however, remain largely unknown. Previous
studies suggested both independent and inter-dependent
relationships between the actions of ECMs and GFs in the
regulation of cell motility. Tucker et al. (1991) reported that
GFs serve as a ‘‘substratum conditioning’’ role in accelerating
collagen-mediated cell locomotion. Klemke et al. (1994)
showed that GFs can make cells migrate on ECMs, on which
the same cells do not migrate in the absence of GFs. In the
reverse, Ware et al. (1998) reported that ECMs influence GF-
stimulated migration speed and directional persistence.
Furthermore, Li and co-workers recently showed that,
whereas ECMs can initiate cell migration without GFs
present, GFs do not have any primary pro-motility effect on
cells that are not attached to an immobilized pro-motility
ECM. The role of GFs is instead to optimize ECM-initiated cell
migration and to provide cell directionality (Li et al.,
2004b, c). Therefore, haptotaxis (ECM driven; Carter, 1967)
is the pre-requisite for chemotaxis (GF driven) to take place.
On the other hand, haptotaxis can occur without GFs
(reviewed by Li et al., 2004b).
Protein kinase Cd (PKCd) is a widely expressed member of
the PKC subfamily. PKCd activation is diacylglyceral depen-
dent, but calcium independent (Gschwendt, 1999). Among
the 13 PKC members, PKCd is the only PKC member that
is a substrate for protein tyrosine kinases. Insulin-like growth
factor-1, platelet-derived growth factor-BB (PDGF-BB),
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epidermal growth factor (EGF), H2O2, phorbol 12-myristate
13-acetate (PMA), ATP, IgE receptor activation, and activated
Src kinases induce tyrosine phosphorylation of PKCd in intact
cells (Denning et al., 1993, 1995; Gschwendt et al., 1994;
Haleem-Smith et al., 1995; Konishi et al., 1997; Kronfeld
et al., 2000; Joseloff et al., 2002). In cultured cells, PKCd is
antiproliferative and tumor suppressing in rat fibroblasts (Lu
et al., 1997), pro-apoptotic in Hela and NIH 3T3 cells
(Ghayur et al., 1996; Liu et al., 2003), pro-motile in epithelial
cells and dermal fibroblasts (DFs) (Andre et al., 1999; Li et al.,
2002; Mimura et al., 2004) and in smooth muscle cells (Li
et al., 2003), and pro-differentiating in human keratinocytes,
cells of myeloid origin, and neuronal cells (Macfarlane and
Manzel, 1994; Denning et al., 1995; Corbit et al., 1999;
Junttila et al., 2003). Some of these in vitro observations, such
as antiproliferation function, were confirmed in vivo in PKCd-
deficient mice (Mecklenbra˚uker et al., 2002; Miyamoto et al.,
2002). In contrast, the others, such as antitumor and
antiapoptotic functions, were not verified in these mice. No
cancer-related deaths in these mice suggest that the lack of
PKCd does not predispose the animals towards cancer
(Miyamoto et al., 2002). Goff’s group recently showed that
the c-Abl and ATM (ataxia telangiectasia mutation)-mediated
oxidative stress responses were blocked in calvarial osteo-
blasts isolated from PKCd-deficient mice, suggesting that the
pro-development and post-development roles for PKCd are
different (Li et al., 2004).
Human DFs play critical roles in skin wound healing and
post-wound remodeling, in which cell motility is a rate-
limiting event (Singer and Clark, 1999). PDGF-BB was one of
the best-characterized GFs that stimulate DF motility in vitro
(Deuel et al., 1991; Heldin and Westermark, 1999; Li et al.,
2004a), possibly by stimulating the cells to produce
fibronectin (Blatti et al., 1988), collagen (Lepisto et al.,
1996), hyaluronic acid (Heldin et al., 1989), and collagen-
ases (Bauer et al., 1985). It has been recently shown that
PDGF-BB is the physiologic pro-motility factor for DFs in
human serum, the main source of soluble GFs in the wound
fluid, and type I collagen is the strongest motile ECM for DF
migration (Li et al., 2004a). In the current study to further
understand the specific signaling mechanisms by which
collagen and PDGF-BB regulate DF migration, we focused on
the cellular localization and function of PKCd under the
following defined conditions: (1) on collagen in the absence
of PDGF-BB to study whether PKCd plays a role in collagen-
initiated migration; and (2) on collagen plus PDGF-BB to
study whether PKCd mediates PDGF-BB-enhanced DF
migration. We provide evidence that PDGF-BB stimulates
rapid translocation and clustering of PKCd at the leading edge
of polarized DFs, where it mediates PDGF-BB-induced cell
migration signals.
RESULTS
PDGF selectively stimulates PKCd to undergo membrane
translocation and leading edge clustering in polarized DFs
To study the role of PKC in the control of DF migration in
response to PDGF-BB, we first examined what PKC family
members are expressed in DFs by carrying out immunoblot-
ting assays using antibodies that individually and specifically
recognize 10 PKC family members, including the six DAG-
sensitive PKC isoforms. As shown in Figure 1, expression of
nine of the 10 PKC isoforms tested were detected at various
levels in DFs (lanes 2). The sole exception was the absent
expression of PKCZ. More intriguingly, both the number of
PKC isoforms and the relative expression levels in DFs were
significantly higher than those in the three other types of
control cells (lanes 1, 3, and 4). Immunoblotting p38
mitogen-activated protein kinase (MAPK) on a duplicate
membrane was included as control for equal (total cellular
proteins) sample loading (panel k).
We then studied which PKC isoform(s) is specifically
activated in DFs by PDGF-BB stimulation. We chose
membrane translocation over phosphorylation, whose effects
on PKC activation are often controversial, or in vitro kinase
assay, whose substrate specificity lacks physiological data
support. We focused on immunofluorescence staining of the
six DAG-sensitive PKC isoforms, a, b, g, e, d, and y. As shown
in Figure 2, in DFs on collagen in the absence of any soluble
GFs, the distribution of the six PKC isoforms was largely
cytosolic and some nuclear, as well (panels a, d, g, j, m, and
p). PDGF-BB stimulation did not cause clear and statistically
significant membrane translocation of PKCa (panel b), PKCb
(panel e), PKCg (panel h), and PKCy (panel q). For instance,
the weaker membrane translocation of PKCg (panel h) did not
convince us to conclude that the translocation was signifi-
cant. This is not owing to the possibility that different PKC
isoforms follow distinct kinetics of translocation, because
similar results were obtained at other time points of PDGF-BB
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Figure 1. DF expresses multiple isoforms of the PKC family kinases.
(a–k) Equal amounts of total cell lysates of the indicated cell types, which
were serum-starved overnight, were resolved in duplicates in SDS-PAGEs,
transferred to nitrocellulose membranes and immunoblotted with a panel of
antibodies specifically against PKC isoforms. A duplicate membrane was
blotted with anti-p38 MAPK antibody as sample loading control. This
experiment was repeated twice and similar results were obtained.
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stimulation (data not shown). Lack of membrane transloca-
tion of these PKC isoforms was not owing to failure of the
antibodies to recognize their antigens. At 15 minutes, PMA-
stimulated membrane translocation of PKCa (panel c), PKCg
(panel i), and PKCd (panel o) was clearly detected by
immunofluorescence staining of the cells with the same
antibodies. However, the membrane translocation PKCb
(panel f), PKCe (panel l), and PKCy (panel r) was more
clearly detected at 5 minutes of PMA treatment (data not
shown).
In contrast, PDGF-BB potently stimulated membrane
translocation of PKCd inB70% of the 80–120 cells examined
(panel n). More intriguingly, the membrane-translocated
PKCd clustered at the leading edge of PDGF-BB-stimulated
and -polarized DFs (pointed by arrows). In comparison, the
leading edge clustering of PKCd was not detected in the PMA-
treated cells (panel o). We also detected PDGF-BB-stimulated
membrane translocation of PKCe (panel k) in B30% of the
80–120 cells examined. We decided to focus our further
studies on PKCd.
To verify the above finding that PDGF-BB strongly
stimulates PKCd to translocate to the leading edge of
polarized DFs, we carried out time-course analysis of
immunofluorescence staining of PKCd in DFs following
PDGF-BB stimulation for various periods of time. As shown
in Figure 3, in DFs on collagen in the absence of PDGF-BB,
PKCd evenly distributed in the cells (panel a). This is not
owing to possible desensitization of PKCd translocation over
the time of incubation. Similar results were obtained when
the serum-starved cells were freshly lifted by trypsin,
remained in suspension for 45 minutes (to calm down stress
signals), and then plated on collagen-pre-coated coverslips
for 45 minutes (the minimum time for the cells to attach and
survive subsequent washing and fixation procedures (data not
shown). However, in response to PDGF-BB stimulation, a
clear and time-dependent membrane translocation of PKCd
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Figure 2. PDGF-BB strongly stimulates membrane clustering of PKCd at the
leading edge of DFs. (a–r) DFs, cultured in collagen-pre-coated coverslip
chambers and serum-starved overnight, were treated without or with
PDGF-BB (15 ng/ml) or PMA (100 nM) for 15 minutes, in which maximum
translocation of PKCd was detected. The cells were fixed, permeabilized, and
immunostained with antibodies specifically against each of the six DAG-
sensitive PKC isoforms expressed in DFs. Eight to 120 randomly selected cells
by each antibody staining were analyzed. The percentages of the cells that
represent the images were estimated and shown.
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Figure 3. An early and transient event of PDGF-BB-stimulated membrane
translocation and leading edge clustering of PKCd. (a–d) DFs, cultured in
collagen-pre-coated coverslip chambers and serum-starved overnight, were
untreated or treated with PDGF-BB (15 ng/ml, the optimal concentration for
cell migration) for the indicated time. Cells were fixed, permeabilized, and
immunostained with anti-PKCd antibody. The localization of the bound anti-
PKCd antibodies were indicated by a GFP-conjugated secondary antibody
and visualized under a fluorescent microscope. Randomly selected 80–120
cells under each condition were analyzed and the percentages of the cells that
represent the displayed images were shown.
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was detected (panels b–d). More intriguingly, PKCd not only
translocates to the plasma membrane but also rapidly clusters
at the leading edge of the cells in a time-dependent manner.
The leading edge clustering was clearly detected around
15 minutes (panel c), sustained for at least 45 minutes (panel
d), and then significantly declined after 90 minutes following
PDGF-BB stimulation. These conclusions were based on
analyses of 80–120 individual cells under each condition and
the percentage of the cells sharing the image under a given
condition over total cells examined (shown on the left). There-
fore, collagen signaling does not cause PKCd membrane
translocation and PDGF-BB does.
Requirement of PKCd kinase function for its sustained, but not
the initial, membrane translocation
To further study the mechanism of PKCd translocation and
clustering, we investigated whether the protein kinase activity
of PKCd is required. To answer this question, we constructed
green fluorescent protein (GFP)-wild-type PKCd (PKCd-wt)
and GFP-kinase-defective PKCd (PKCd-KD) fusion genes and
cloned them into lentiviral vector, pRRLsinhCMV, which
offers more than 90% gene transduction efficiency to primary
human DFs (Chen et al., 2003; Li et al., 2004a). As shown in
Figure 4, in DFs attached to collagen in the absence of PDGF,
both GFP-PKCd-wt and GFP-PKCd-K396R distributed evenly
in the cytoplasm and some also at the periphery of the
nucleus (panels a and b). During the early period (5 minutes)
of PDGF-BB stimulation, membrane translocation of both
GFP-PKCd-wt and GFP-PKCd-K396R was detected (panels c
and d, pointed by arrows). Interestingly, however, GFP-PKCd-
wt was able to maintain its presence at the leading edge of
the cells for 90 minutes following PDGF-BB stimulation
(panels e, g, and i). In contrast, membrane localization of
the GFP-PKCd-KD was transient and became undetectable
after 15 minutes of PDGF-BB stimulation, even though the
cell polarization persisted (panels f, h, and j). These data
indicate that (1) the kinase function of PKCd is not required
for cell polarization or the initial membrane translocation of
PKCd; (2) however, it is critical for its sustained membrane
localization and cell leading edge clustering.
Requirement of PKCd for PDGF-enhanced DF migration, but
not for collagen-initiated migration
Our recent studies showed that ECMs initiate cell migration,
whereas soluble GFs are unable to initiate migration in the
absence of an ECM. The function of soluble GFs, such as
PDGF-BB, is to enhance ECM-initiated migration and provide
directionality for cell migration (Li et al., 2004a, b, c).
Therefore, we were specifically interested in whether PKCd
signaling is required for ECM-driven or GF-driven DF
migration, or both.
We first carried out the in vitro wound-healing assay,
which measures averaged and unidirectional migration of a
cell population. The unclosed distance of multiple
‘‘wounded’’ areas was measured and quantitated as an
‘‘average gap’’ (Li et al., 2004c). As shown in Figure 5, DFs
infected with vectors (sin or FG12) alone did not migrate on
an uncoated surface (panels a and g). The cells modestly
migrated on collagen in the absence of any GFs (panels b and
h). However, the cells on collagen in the presence of PDGF-
BB completely closed the ‘‘wounded’’ areas (panels c and i).
DFs expressing PKCd-wt or FG12-Lac-Z-small interfering
RNA (siRNA) showed similar degrees of migration (panels d
and j). DFs expressing either PKCd-KD or PKCd-siRNA were
still able to migrate on collagen (panels e and k). However,
these cells failed to complete the wound closure under
PDGF-BB stimulation (panels f and l vs. panels c and i). These
data established again that PKCd is specifically required
for GF-enhanced cell migration, and not involved in
ECM-initiated cell migration.
We then carried out the colloidal gold motility assay,
which measures individual cell motility (Materials and
Methods). The principle of this assay is to have single cells
attach and migrate on an ECM-coated colloidal gold-covered
surface in the presence of a cell proliferation inhibitor. When
the cells move, they leave behind migration tracks that can be
visualized with a dark-field microscope and summed as a
‘‘migration index’’ by computer-assisted analysis (Woodley
et al., 1988). We used the lentiviral system-established DFs,
which express either PKCd-siRNA or a PKCd-KD mutant, for
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Figure 4. Requirement of the PKCd kinase function for sustained membrane
accumulation of PKCd. (a–j) To study the role of its kinase domain, GFP-
PKCd-wt and GFP-PKCd-KD fusion genes were constructed and cloned into
lentiviral vector, pRRLsin-MCS-Deco. DFs, infected with GFP-PKCd-wt or
GFP-PKCd-KD, were untreated or treated with PDGF-BB (15 ng/ml) for the
indicated time, fixed, and directly analyzed under fluorescent microscope.
Randomly selected 80–120 cells under each condition were analyzed. The
percentages of the cells that represent the images shown were estimated.
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the cell migration assays. As shown in Figure 6a–i, serum-
starved DFs could not migrate in the absence of both ECM
and GF (panel a, arrows point to the cells.). However, as
expected, DFs migrated on a collagen-coated surface in the
absence of PDGF (panel b). The addition of PDGF-BB further
enhanced DF migration on collagen (panel c). Downregula-
tion of PKCd by PKCd-siRNA dramatically inhibited
the PDGF-BB-stimulated DF migration (panel i vs. panels c
and f). Under these conditions, however, the collagen-
initiated migration was unaffected (panel h vs. panels e and
b). Quantitation of the migration data, as shown in Figure 6j,
clearly indicated that PKCd selectively mediates PDGF-BB-
enhanced progression of DF migration (bar 9 vs. bars 3 and
6), but not collagen-driven initiation of the migration (bar 8
vs. bars 5 and 2).
Consistent with the above finding, as shown in Figure
6k–y, DFs infected with either the vector alone (panels n, o,
and p) or with PKCd-wt (panels q, r, and s) showed similar
results. The cells did not migrate on uncoated surface (panels
n and q), modestly migrated on collagen alone (panels o and
r) and maximally migrated on collagen in the presence of
PDGF-BB (panels p and s). Interestingly, DFs expressing
PKCd-KD were still able to migrate on collagen (panel u), but
failed to complete the PDGF-BB-enhanced migration (panel
v), suggesting again that PKCd is required for PDGF-
enhanced, but not for collagen-initiated DF migration. As a
positive control, overexpression of MEK1-KD (Li et al.,
2004a), a dominant-negative inhibitor of the extracellular
signal-regulated kinase1/2 (ERK1/2) pathway, inhibited both
the collagen-initiated (panel x vs. panel w) and PDGF-BB-
enhanced (panel y) DF migration. Quantitation of the data is
shown in Figure 6z.
We finally tested if activation of PKCd alone can replace
the PDGF-BB stimulation. DFs were infected with either
PKCd-wt or a constitutively activated PKCd (PKCd-R144/
145A) and the cells were subjected to colloidal gold
migration assays. As shown Figure 6aa–ff, expression of
PKCd-R144/145A alone partially mimicked the enhancing
effect of PDGF-BB stimulation of DF migration under GF-free
conditions (panel ee vs. panels aa and cc). PDGF-BB
stimulation of the DF-PKCd-R144/145A cells caused slightly
stronger migration than the PDGF-BB-stimulated migration in
either vector or PKCd-wt infected DFs (panel ff vs. panels bb
and dd). Quantitation of the data is shown in Figure 6gg.
These data indicated again that activation of PKCd is critical
for PDGF-BB-stimulated DF migration.
PKCd does not act upstream of MAPK cascades in PDGF-BB-
stimulated DFs
While the downstream signaling mechanism by PKCd
remains poorly defined, whether or not PKCd acts as a direct
upstream activator of the MAPK family kinases has been a
debated issue (see Discussion). Therefore, we tested if
overexpression of the PKCd-KD mutant blocks PDGF-BB-
stimulated the signature Thr-x-Tyr phosphorylation in p38,
ERK1/2, and c-Jun N-terminal kinase (JNK). DFs were
infected with lentiviral vector carrying either PKCd-wt or
PKCd-KD mutant (Li et al., 2004b). To verify exogenous
expression of the infected PKCd, lysates of these cells were
subjected to immunoblotting analyses with antibody against
PKCd. The lower portion of the same membrane was excised
and immunoblotted with anti-p38 antibody as the sample
loading control. The data were quantitated, based on
densitometry scanning indices of the PKCd bands, against
each of their own p38 control band. As shown in Figure 7a
and b, the expression of the exogenous PKCd-wt and
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Figure 5. PKCd plays a critical role in PDGF-BB-stimulated, but not
collagen-initiated, DF migration in vitro kinase assay. (a–l) DFs with
overexpressed PKCd-KD and DFs with downregulated PKCd by siRNA were
subjected to in vitro wound-healing assays, under three defined conditions:
(1) ECM free and GF free (/); (2) collagen coating and GF free (þ /); and
(3) collagen and PDGF-BB (þ /þ ). All experiments were stopped in 16 hours
and wound closure analyzed. The wound closures were photographed and
the quantitation (average gap, or AG) was carried out as described (Li et al.,
2004b). The results shown here are reproducible in three independent
experiments.
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PKCd-KD was nine to six times greater than the endogenous
PKCd (lanes 3–6 vs. lanes 1 and 2). The same cell lysates were
then analyzed by immunoblotting analyses with antibodies
against either the phosphorylated p38, ERK1/2, and JNK or
their proteins. As shown in Figure 7c and d, PDGF-BB clearly
stimulated the phosphorylation of p38 in DFs (lane 2 vs. lane
1). Overexpression of PKCd-wt showed neither a stimulatory
nor an inhibitory effect on p38 phosphorylation (lanes 3 and
4). Interestingly, overexpression of PKCd-KD mutant did not
block PDGF-BB-stimulated activation of p38 (lane 6 vs. lane
2). In contrast, we detected a slightly increased basal
phosphorylation of p38 (lane 5), although the reason for this
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Figure 6. PKCd plays a critical role in PDGF-BB-stimulated, but not collagen-initiated, DF migration in colloidal gold migration assay. DFs, in which PKCd
signaling was blocked by either siRNA downregulation of the endogenous PKCd or exogenously overexpression of PKCd-KD, were subjected to colloidal gold
migration in assays under three defined conditions: (1) ECM free and GF free (‘‘control’’); (2) collagen coating and GF free (‘‘collagen’’); and (3) collagen and
PDGF-BB (‘‘collagenþPDGF’’). The cell migration in all experiments was stopped in 16 hours and analyzed. (a–i, j) DFs with downregulated PKCd by siRNA on
colloidal gold migration assays and quantitation (migration index). (k–y, z) DF-overexpressing PKCd-KD or MEK1-KD in colloidal gold migration assays and
quantitation (migration Index). (aa–ff and gg) DF-overexpressing constitutively activated PKCd-R144/145A in colloidal gold migration assays and quantitation
(migration index).
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remains unclear. Similarly, inhibition of PKCd did not
block PDGF-BB-stimulated ERK1/2 and JNK activation.
Both PKCd-wt and PKCd-KD slightly enhanced PDGF-BB-
stimulated activation of ERK2 (Figure 7e, lanes 4 and 6).
Overexpression of PKCd-wt showed little effect, whereas
overexpression of PKCd-KD even enhanced PDGF-BB-
stimulated activation of the p46 JNK (Figure 7g, lanes 4, 6).
Although, the reason for the enhancement remains unclear,
we concluded that PKCd does not act as a direct upstream
activator of p38, ERK1/2, and JNK cascades in DFs in
response to PDGF-BB. However, expression of the PKCd-KD
mutant completely blocks PDGF-BB-stimulated DF migration
(as shown in Figure 6).
Several groups showed that p38 acts downstream of PKCd
in control of cell migration, largely based on the effect of the
chemical PKCd inhibitor, rottlerin (Igarashi et al., 1999;
Rahman et al., 2001; Tanaka et al., 2003; Yamaguchi et al.,
2004). Moreover, we showed that p38 is activated by PDGF-
BB in DFs and involved in PDGF-BB-stimulated DF migration
(Li et al., 2004a). Therefore, we further studied whether PKCd
is an upstream activator of p38 in DFs. As previously
mentioned, we constructed RNA interference (RNAi) against
PKCd into the lentiviral vector-derived siRNA delivery
system, FG12, which permanently expresses siRNA of
interest in the cells (Qin et al., 2003). Following a single
infection, FG12 vector-mediated siRNA transduction effi-
ciency was measured via the co-expressed GFP gene. As
shown in Figure 7i and j, FG12 vector alone or control FG12-
Lac-Z-siRNA did not cause any significant downregulation of
PKCd (i, lanes 2 and 3 vs. lane 1). In contrast, infection with
the PKCd-siRNA downregulated more than 75% of the
endogenous PKCd (lane 4 vs. lanes 1–3). The lower portion
of the same membrane was immunoblotted with anti-p38
antibody as sample loading control (panel j). However, under
these conditions, PDGF-BB was still able to stimulate p38
phosphorylation (Figure 7k and l, lane 6 vs. lane 2). As
controls, neither the vector alone nor the Lac-Z-siRNA
showed any effect on p38 activation (lanes 2 and 4). Finally,
we carried out a p38 MAPK in vitro kinase assay, which is
accepted as the ultimate way of measuring p38 MAPK
activity. In this assay, p38 MAPK was immunoprecipitated
from DFs, either overexpressing the PKCd-KD mutant or the
PKCd-siRNA. The immune complexes were subjected to
kinase reactions using ATF-2 as the protein substrate and
phosphorylation of ATF-2 was used as the readout (Materials
and Methods). As shown in Figure 7m and n, neither
overexpression of the PKCd-KD mutant nor downregulation
of the endogenous PKCd by PKCd-siRNA inhibited the PDGF-
BB-stimulated p38 activation, that is, phosphorylation of
ATF-2 (panel m, lanes 4 and 6 vs. lane 2). Similar amounts of
p38 proteins were immunoprecipitated (panel n). Therefore,
these data clearly indicated that PKCd does not act upstream
of p38 MAPK. To further confirm the above observations, we
tested the activation of these MAPKs in DFs that exogenously
express the constitutively activated PKCd-R144/145A. As
shown in Figure 7o–r, although the expression of PKCd-R144/
145A alone greatly enhanced DF migration (see Figure 6aa–ff
and gg), it showed no effects on PDGF-BB-stimulated
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Figure 7. PKCd is not a direct activator of the three major MAPK cascades.
Three approaches were used to interrupt PKCd signaling, overexpression of
PKCd-KD mutant, downregulation of the endogenous PKCd by PKCd-siRNA,
and overexpression of constitutively activated PKCd-R144/145A mutant. (a, b)
Western blot of the DF-expressing vector, PKCd-wt, or PKCd-KD. The lower
part of the same membrane was blotted with anti-p38 antibody. (c–h) Lysates
of DFs, overexpressing vector control, PKCd-wt, or PKCd-KD, were equalized
and resolved in SDS-PAGEs. Duplicate gels were analyzed by Western
immunoblotting analyses using antibodies specifically against the phos-
phorylated forms of (panel c) p38 , (panel e) ERK1/2, and (panel g) JNK, or
(panels d, f, and h, respectively) their peptides. This experiment was repeated
multiple times. (i, j) Downregulation of the endogenous PKCd protein by
FG12 infection with siRNA against PKCd, as shown by a Western blot. (k, l)
PDGF-BB-stimulated p38 phosphorylation was analyzed in DF-expressing
siRNA against PKCd or vector and Lac-Z-siRNA controls. (m, n) DFs,
expressing vector control, PKCd-KD, or PKCd-siRNA, were lysed by lysis
buffer for in vitro kinase assay supplied by the manufacturer. p38 was
immunoprecipitated by anti-p38 antibodies linked to argarose beads. (panel
m) The immune complexes were then subjected to in vitro kinase assay using
purified ATF-2 as the substrate. Phosphorylation of ATF-2 was used as the
readout and quantitated by scanning densitometry. (panel n) The immuno-
precipitation was monitored by blotting the membrane with an anti-p38
antibody. (o-r) Lysates of DFs, overexpressing PKCd-wt or PKCd-R144/145A,
were analyzed by Western immunoblotting analyses using antibodies
specifically against the phosphorylated forms of (panel o) p38, (panel p) ERK1/
2 and (panel q) JNK , or (panel r) b-actin, respectively. (s–v) Lysates of DFs,
either treated with increasing concentrations of rottlerin or overexpressing
vector control, PKCd-wt, or PKCd-R144/145A and being treated with PDGF-
BB (50 ng/ml) for the indicated time, were equalized and resolved in SDS-
PAGEs. Duplicate gels were analyzed by Western immunoblotting analyses
using antibodies specifically against the phosphorylated forms of (panels s and
u) Stat3, or (panels t and v) their peptides. These experiments were repeated
multiple times and similar results were obtained.
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activation of p38 (panel aa), ERK (panel bb), or JNK (panel cc)
with anti-b-actin blot as the control (panel dd).
Jain et al. (1999) first reported that PKCd associates with
and phosphorylates signal transducer and activator of
transcription 3 (Stat3) at ser-727 in several cell lines in
response to IL-6. Therefore, we tested if inhibition of PKCd
affects PDGF-BB-stimulated ser-727 phosphorylation of Stat3
in DFs. We used both a chemical inhibitor of PKCd, rottlerin,
and PKCd-siRNA. As shown in Figure 7s and t, pre-incubation
of DFs with increasing concentrations of rottlerin decreased
PDGF-BB-stimulated phosphorylation of Stat3 in a dose-
dependent manner (panel s, lanes 2–6). Similar results were
obtained in DF-expressing PKCd-siRNA. As shown in Figure
7u and v, downregulation of PKCd by 75% (see Figure 7i and
j) significantly blocked PDGF-BB-stimulated phosphorylation
of Stat3 in DFs (lane 6 vs. lanes 2 and 4).
DISCUSSION
We have provided evidence that, under the optimal condi-
tion for DF migration in vitro, that is, collagen as the ECM and
PDGF-BB as the GF (Li et al., 2004a), PKCd translocates to
the leading edge of polarized DFs and selectively mediates
PDGF-BB-enhanced, but not collagen-initiated, migration.
Although the initial translocation did not appear to require a
functional kinase domain of PKCd, the PKCd-KD failed to
sustain its presence at the membrane, in comparison to the
PKCd-wt. However, in contrast to previous reports that PKCd
act as upstream activator of the MAPK cascades, our results
show that PKCd does not mediates PDGF-BB-induced
activation of the three major MAPK pathways, ERK1/2, p38
MAPK, and JNK, in DFs. Instead, inhibition of PKCd blocks
PDGF-stimulated phosphorylation on ser-727 of Stat3. A
schematic representation of these findings is shown in
Figure 8. PDGF-BB, but not collage, stimulation causes DF
polarization and translocation of PKCd to the migrating front
of the cells. The kinase domain of PKCd stabilizes its
membrane docking, so that it effectively relay the signals.
Although PDGF-BB stimulation activates the three main
MAPK cascades, PKCd does not mediate the activation of
these kinases. One downstream target of PKCd leading to DF
migration might be the activation of Stat3.
The fact that PDGF-BB, but not collagen, causes PKCd
membrane translocation does not necessarily exclude the
possibility that attachment to collagen and activation of
integrin signaling indirectly contributed to the PDGF-BB-
stimulated event. For example, attachment to collagen is
essential for PDGF-BB-stimulated DF polarization to take
place. PDGF-BB could not stimulate DF polarization unless
the cells are attached to an ECM (Li et al., 2004a). Therefore,
if DFs were not polarized, there will be no leading edge
clustering of PKCd. Consistent with this notion, it has been
shown that PDGF-BB and EGF stimulate stronger tyrosine
phosphorylation of PDGFR, EGFR, and the downstream Ras-
MAPK pathway in cells apposed to ECM than cells in
suspension (Miyamoto et al., 1996; Lin et al., 1997; Renshaw
et al., 1997; Moro et al., 1998). Del Pozo et al. (2000)
showed that, whereas GFs could activate Rac GTPase
(guanosine triphosphate bound) in suspended cells, the
guanosine triphosphate-bound Rac failed to couple to
downstream effectors in the cells. In contrast, in the cells
attached to an ECM, the guanosine triphosphate-bound Rac
translocates to the plasma membrane, where it connects with
a downstream pathway.
Several possible downstream signaling mechanisms of
PKCd were reported, including ERK1/2 (Keshamouni et al.,
2003; Ginnan and Singer, 2005), p38 MAPK (Igarashi et al.,
1999; Rahman et al., 2001; Tanaka et al., 2003; Yamaguchi
et al., 2004), Stat3 (Jain et al., 1999), and myosin light-chain
phosphorylation and activation (Iwabu et al., 2004), In
particular, at the time this paper is written, more than 20
publications reported that p38 MAPK plays a critical role in
migration control of various cell types. Therefore, we used
three independent and more specific approaches (than
rottlerin, previously used by others) to carefully examine if
PKCd acts as an upstream activator of the p38 MAPK in DFs
in response to PDGF-BB: PKCd-KD mutant, siRNA against
endogenous PKCd, and a constitutively activated PKCd. We
found that neither overexpression of PKCd-KD mutant nor
downregulation of the endogenous PKCd by PKCd-RNAi
affected PDGF-BB-stimulated p38 activation. Moreover, the
in vitro kinase assay using purified ATF-2 as the substrate for
p38 kinase, which stands as the most reliable assay for p38
activation, confirmed our finding. Under similar conditions,
however, PDGF-BB-stimulated DF migration was completely
inhibited by PKCd-KD and PKCd-RNAi. Furthermore, expres-
sion of a constitutively activated PKCd (PKCd-R144/145A) did
not lead to increased phosphorylation of neither p38 or ERK
and JNK, although it showed significant enhancement of DF
migration even in the absence of PDGF-BB. Therefore,
considering the fact that rottlerin also inhibits many other
protein kinases and non-kinase enzymes (Davies et al., 2000;
McGovern and Shoichet, 2003), the previously observed
inhibition of p38 activation by rottlerin may not be owing to
specific inhibition of PKCd.
One possible downstream target for PKCd-mediated DF
migration in response to PDGF-BB stimulation is Stat3. Sano
and co-workers showed that germline Stat3 ablation led to
embryonic lethality. However, in K5-Cre;Stat3(flox/) (skin-
specific) transgenic mice, wound-healing processes were
PDGFR
PDGF
Integrin Integrin
Collagen Collagen
PKC MAPKs
Stat3
Migration
Figure 8. A schematic working model for PKCd signaling in DF migration
during wound healing. The cells on collagen in the absence of PDGF do not
undergo polarization and PKCd does not translocate to the membrane. PDGF
stimulation causes the PDGF receptor to dimerize and PKCd to cluster at the
leading edge of polarized cells. The membrane-bound PKCd mediates PDGF-
stimulated migration signals. However, PKCd does not relay the motility
signal to any of the three major MAPK cascades. Instead, it appears to act
upstream of Stat3, a critical factor in skin cell migration and wound healing
(Sano et al., 1999). The relative numbers and proportions of the signaling
molecules shown do not quantitatively reflect them in the cells.
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severely compromised, largely owing to impaired cell
migration in response to growth factor (Sano et al., 1999).
The authors concluded that Stat3 plays a crucial role in
transducing a signal required for migration but not for
proliferation of skin cells, and that Stat3 is essential for skin
remodeling, including hair cycle and wound healing. In
addition, Stat3 has been shown to be critical for the
development of psoriasis and epithelial carcinogenesis in
mice (Chan et al., 2004; Pedranzini et al., 2004; Sano et al.,
2005). Therefore, in our system, it is conceivable that PDGF-
BB stimulates activation of PKCd, which in turn activates
Stat3, leading ultimately to DF migration.
MATERIALS AND METHODS
Primary human DFs were purchased from Cascade Biologics
(Portland, OR) and cultured in DMEM supplemented with 10% fetal
bovine serum, according to the manufacturer’s instruction. DFs at
passages 4 to 5 were used in all the experiments throughout this
study. Native rat-tail type I collagen was from BD Biosciences
(Bedford, MA). PDGF-BB, poly-L-lysine (P-1274), and colloidal gold
(gold chloride, G4022) were purchased from Sigma (St Louis, MI).
Anti-PKC antibody kit (611421) was from BD Transduction
Laboratories (Lexington, KY). Anti-p38 (a) antibody (sc-535) and
anti-JNKK2 antibody (T-19) were from Santa Cruz Biotechnology
(Santa Cruz, CA). Anti-ERK1/2 antibody (03-6600) was from Zymed
Laboratory (South San Francisco, CA). Anti-phospho-ERK1/2 anti-
body (V803A) was from Promega (Madison, WI). Anti-phospho-p38
antibody (no. 9,211) and anti-phospho-JNK antibody kit (no. 9,250)
were from Cell Signaling (Beverly, MA). p38 MAP Kinase Assay Kit
was from Cell Signaling (Beverly, MA). Anti-phospho-Stat3 (ser-727)
(6E4) was from Cell Signaling. Anti-Stat3 antibody (B-7) was from
Santa Cruz Biotechnology. All restriction enzymes, T4 DNA ligase,
and CIP were from New England BioLabs (Beverly, MA). Plasmid
Midi Kit (no. 12,143) was from Qiagen (Valencia, CA). XL-10 Gold
Ultra competent cells (XL-10 Gold) were from Stratagene (Kingsport,
TN). All other reagents and supplies, unless indicated, were from
VWR (Bristol, CT) or Sigma.
Screening PKC family gene expression in DFs
Serum-starved DFs, as well as human 293, human leukemia cell line
K562, and human keratinocytes, were washed with PBS and
solubilized under the conditions as previously described by us (Li
et al., 1991). The total cellular proteins were equalized by their OD
readings using Bio-Rad Protein Assay. Equal amounts (B30 mg total
cellular proteins/sample) were resolved in multiple and identical
SDS gels, which were then subjected to Western blot analyses with
multiple anti-PKC antibody kit (Materials and Methods). The results
were visualized by ECL (Amersham) and simultaneous and
unsaturated exposures were used to assess the relative expression
levels of the various PKC isoforms. Under these conditions,
calculations for fold increases by scanning densitometry were not
possible, since the affinities of the different antibodies are unknown.
Immunostaining and microscopic analyses
The procedure for staining DFs with antibodies was performed as
previously described by us (Li et al., 2004a–c). The images of the
stained cells were visualized under fluorescent microscopy (ZEISS,
Axioplan) and photographed with a digital camera (AxioCam-MRm,
ZEISS). Eighty to 120 cells were analyzed for morphological
polarization under each of the experimental conditions, as described
previously (Etienne-Manneville and Hall, 2001). Morphological
polarization occurs concomitantly with the reorientation of micro-
tubule-organizing center in the direction of cell migration. We
constantly used antipericentrin antibody staining to visualize
microtubule-organizing center and found that microtubule-organiz-
ing center staining correlates with PKCd localization in PDGF-BB-
stimulated cells. Percentages of the polarized cells versus total cells
were calculated.
Subcloning, production of lentiviral stocks, and infection
The lentivirus-derived vector, pRRLsinhCMV, was inserted with
PKCd-wt or kinase-defective PKCd-K396R (PKCd-KD) (at Bam-
HIþ EcoRI). These constructs were used to transfect 293 T cells
together with two packaging vectors, pCMVDR8.2 and pMDG, to
produce virus stocks as described previously (Chen et al., 2003).
Conditioned media were collected, filtered, and concentrated, if
necessary, before being used to infect cells. DFs were plated 1 day
prior to infection in six-well tissue culture plates at 25% confluence
and subjected to infection as described previously (Li et al., 2004b).
A constitutively active PKCd was constructed by mutagenesis of
the pseudosubstrate site of PKCd in pKS-PKCd-2 (Denning et al.,
2002) using the Transformer Site-Directed Mutagenesis Kit (Clon-
tech, Palo Alto, CA). The conserved arginines at 144 and 145 were
mutated to alanines with the mutagenic primer (MFD5: CAAAC
GATGAACGCCGCCGGAGCCATCAAA). The changed bases pairs
are underlined. The mutation in the new construct, pKS-PKCd (R144/
145A), was verified by DNA sequencing. A constitutively active,
myc-tagged PKCd construct was constructed by digesting pKS-PKCd
(R144/145A) with BsgI to remove the pseudosubstrate mutation and
inserting it into pKS-myc-PKCd to generate pKS-myc-PKCd (R144/
145A). This construct was then subcloned into pRRLsinhCMV.
RNAi, lentiviral infection delivery, and quantitation of
transduction efficiency
We used the RNAi Selection Program as described to identify
possible target sequences (Yuan et al., 2004). Six potential sites were
selected and synthesized. The relative effectiveness of the synthetic
double-stranded siRNA in downregulation of PKCd was measured by
transfecting 293 cells and immunoblotting the cell lysates with
corresponding anti-PKCd antibodies. The most effective RNAi
sequence was then cloned into the lentiviral RNAi delivery vector,
FG-12, as described previously (Qin et al., 2003). The gene
transduction efficiency was analyzed under a fluorescent micro-
scope and by FACS analysis for a co-expressed GFP gene marker in
the same vector. The selected RNAi sequence (sense) against human
PKCd for FG12 cloning was GGCUGAGUUCUGGCUGGAC, which
effectively downregulated PKCd.
Measurement of transgene expression levels
Expression of the gene products and activation of PKCd (membrane
translocation) were detected by either immunoblotting the lysates of
infected cells or immunostaining fixed cells with antibodies against
PKCd. To measure the protein levels of exogenously expressed gene
products over their endogenous counterparts or their activity
following GF stimulation, cell lysates were prepared as described
previously (Li et al., 1991). Equal amounts (50mg total cellular
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proteins/sample) of equalized cell lysate proteins (measured by Bio-
Rad Protein Assay) were subjected to Western blot analysis and the
results visualized by ECL (Amersham). Autoradiographs with an
unsaturated exposure were used to assess the approximate fold
increase by scanning densitometry. Means from three different
exposures of the same experiment were calculated and taken as the
averaged fold increase.
Computer-assisted colloidal gold cell motility assay
The colloidal gold migration assay was previously described by
Albrecht-Buehler (1977) and subsequently modified for a computer-
assisted analysis (Woodley et al., 1988). An updated protocol, data
analysis, and statistic analysis on DF were detailed recently (Li et al.,
2004b).
In vitro wound-healing assay
The in vitro wound-healing assay was recently modified and
described in detail by us (Li et al., 2004c). The key modifications
are that (1) the surface of the tissue culture plates or glass coverslips
was pre-coated with an ECM or non-motile polylysine prior to
plating cells on them and (2) the wounds/scratches were made
within 2–3 hours after the cells attached and wound closure detected
in 16 hours. The pre-coated ECMs and the relatively short cell
attachment period prevent possible deposition of secreted ECMs by
the cells. To test whether the pre-coated collagen was damaged by
the scratching procedures, the coated plates without cells in it were
scratched, and stained with anticollagen antibodies and followed by
a fluorescence-conjugated secondary antibody. Overall, there were
insignificant differences found between the scratched area and
unscratched area, except that limited and scattered scratches were
visible in the scratched area under the fluorescence microscope.
Mitomycin C (10 mg/ml) was included throughout the experiments to
prevent cell proliferation.
All experiments have the institutional approval of the University
of Southern California and adhere to the Declaration of Helsinki
Principles.
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